2019 American Transplant Congress
Effects of Statin Use on Cardiovascular Outcome in Patients with Renal Transplantation
*Purpose: Cardiovascular disease is the main cause of death among patients with end-stage renal disease (ESRD). Statin, HMG-CoA reductase inhibitor, is well known to significantly…2019 American Transplant Congress
When to Hold: Apixaban in Renal Transplant Recipients
1Yale New Haven Hospital, New Haven, CT, 2Yale School of Medicine, New Haven, CT
*Purpose: Renal transplant recipients (RTRs) may develop deep venous thrombosis (DVT), pulmonary embolism (PE), or atrial fibrillation requiring treatment with oral anticoagulation. There is limited…2019 American Transplant Congress
Racial Disparities in Documentation of Non-Adherence and Its Relation to Rejection in Pediatric Kidney Transplant Recipients
*Purpose: Black patients have historically been disadvantaged throughout the transplant process. Many factors impact the success of kidney transplantation, but the need for strict adherence…2019 American Transplant Congress
Prevalence of Diabetes after Transplant in a Single Center
*Purpose: The investigators aim to study the prevalence of post kidney transplant diabetes (NODAT) in a single Asian pediatric centre and to identify clinical factors…2019 American Transplant Congress
Late Onset J C Virus Allograft Nephropathy
University of Illinois Health, Chicago, IL
*Purpose: JC virus(JCV) is a member of the Polyomaviridae family. Few studies have been published regarding the replication of JCV in transplant recipients. The incidence…2019 American Transplant Congress
Microsteatosis in Livers from Donation after Circulatory Death (DCD) Donors is Associated with Inferior Graft and Patient Survival Following Liver Transplantation (LTX)
University of Wisconsin, Madison, WI
*Purpose: The current theory is that severe macrosteatosis (MaS) (>50%) in livers recovered from donation after brain death (DBD) donors leads to increased rates of…2019 American Transplant Congress
Analysis Of Public Health Service Increased Risk Donors Shows No Viral Transmission In Liver Transplant Recipients And Similar Graft / Patient Survival When Compared To Non-increased Risk Donors
Department of Surgery, The Dumont-UCLA Transplant Center, Los Angeles, CA
*Purpose: Public Health Service increased risk donors (PHS-IRD) are underutilized in liver transplant (LT) due to concern for transmission of viral (HBV, HCV, and HIV)…2019 American Transplant Congress
Management and Outcome of Hepatic Artery Thrombosis in Pediatric Liver Transplantation
Pediatric Surgery and Transplantation Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium
*Purpose: Hepatic artery thrombosis (HAT) still constitutes a particular challenge in terms of prevention and management in pediatric liver transplantation (LT). This work reviews the…2019 American Transplant Congress
Oral Ribavirin Therapy for Respiratory Syncytial Virus (RSV) in Lung Transplant Recipients: The Impact of Policy Implementation on Cost and Appropriate Use
Henry Ford Hospital, Detroit, MI
*Purpose: RSV is a leading cause of viral infections in lung transplant recipients and is associated with significant morbidity and mortality. While the role of…2019 American Transplant Congress
Lung Transplantation in the Elderly Patients with Multi-Comorbidities
Temple University Health System / Lewis Katz School of Medicine, Philadelphia, PA
*Purpose: Recently there is an outstanding steadily increase in elderly patients above 70 years old who are referred to our center as potential candidates for…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 214
- Next Page »